Exhibit 99.1

                 Sono-Tek Announces Additional Equity Investment

    MILTON, N.Y., Dec. 9 /PRNewswire-FirstCall/ - Sono-Tek Corporation (OTC
Bulletin Board: SOTK) today announced that due to its desire to finance new
business development and to pay down high interest indebtedness, it had
completed a private placement on December 3, 2004.  In this offering, the
Company sold 76,750 of its units, each unit consisting of four shares of its
common stock and one warrant, each to purchase one additional share of common
stock.  The Company issued 307,000 shares of common stock and 76,750 warrants.
The Company received net proceeds of approximately $530,000 from this
offering.  Sono-Tek's diversification of its product offerings into the
medical device coating field, the glass line coating industry and nano-
technology research, which, when coupled with continuing growth in the
electronics industry has led to a significant increase in revenue and
operating profit to date this year.  Dr. Christopher L. Coccio, President and
CEO, stated "I am very pleased to welcome these new investors to the Sono-Tek
family, and look forward to wrapping up our fiscal year on February 28, 2005
on a positive note with record annual sales levels."

    For further information, contact Dr. Christopher L. Coccio, President and
CEO at 845-795-2020, or visit our website at http://www.sono-tek.com

    Sono-Tek Corporation is a leading developer and manufacturer of liquid
spray products based on its proprietary ultrasonic nozzle technology.  Founded
in 1975, the Company's products have long been recognized for their
performance, quality, and reliability.

    This press release contains forward looking statements regarding future
events and the future performance of Sono-Tek Corporation that involve risks
and uncertainties that could cause actual results to differ materially. These
factors include, among other considerations, general economic and business
conditions; political, regulatory, competitive and technological developments
affecting the Company's operations or the demand for its products; timely
development and market acceptance of new products; adequacy of financing;
capacity additions and the ability to enforce patents. We refer you to
documents that the company files with the Securities and Exchange Commission,
which includes Form 10-KSB and Form 10-QSBs containing additional important
information.

SOURCE  Sono-Tek Corporation
    -0-                             12/09/2004
    /CONTACT:  Dr. Christopher L. Coccio, President and CEO, Sono-Tek
Corporation, +1-845-795-2020/
    /Web site:  http://www.sono-tek.com /
    (SOTK)

CO:  Sono-Tek Corporation
ST:  New York
IN:  CHM OTC
SU:  FNC